Compounds > 2,3-bis(3'-hydroxybenzyl)butyrolactone
Page last updated: 2024-09-02

2,3-bis(3'-hydroxybenzyl)butyrolactone and Metastase

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Metastase in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anant, S; Hegde, MV; Kadam, SS; Mali, AV; Padhye, SB1
Hu, XJ; Li, Y; Liu, CM; Xiong, XY1
Chen, J; Thompson, LU1
Miura, D; Miura, Y; Saarinen, NM; Santti, R; Yagasaki, K1

Reviews

1 review(s) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Metastase

ArticleYear
Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives.
    European journal of pharmacology, 2019, Jun-05, Volume: 852

    Topics: 4-Butyrolactone; Animals; Humans; Lignans; Neoplasm Metastasis; Neoplasms

2019

Other Studies

3 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Metastase

ArticleYear
Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer.
    Nutrition and cancer, 2015, Volume: 67, Issue:8

    Topics: 4-Butyrolactone; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Cytoskeleton; Focal Adhesion Kinase 1; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression; Humans; Ki-67 Antigen; Lignans; Neoplasm Invasiveness; Neoplasm Metastasis; Paxillin; Proliferating Cell Nuclear Antigen; RNA, Messenger; S Phase; Signal Transduction

2015
Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro.
    Breast cancer research and treatment, 2003, Volume: 80, Issue:2

    Topics: 4-Butyrolactone; Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Humans; Lignans; Neoplasm Invasiveness; Neoplasm Metastasis; Phytotherapy; Receptors, Estrogen; Tamoxifen

2003
Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats.
    Nutrition and cancer, 2007, Volume: 58, Issue:1

    Topics: 4-Butyrolactone; Animals; Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Lignans; Liver Neoplasms, Experimental; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Rats; Tumor Cells, Cultured

2007